Skip to main content
Clinical Trials/ISRCTN55359097
ISRCTN55359097
Completed
未知

A method comparison study comparing intra- and inter-user reproducibility of FeNO measurement using the NObreath® V2

Bedfont® Scientific Ltd0 sites186 target enrollmentSeptember 4, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Bedfont® Scientific Ltd
Enrollment
186
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2020
End Date
October 30, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bedfont® Scientific Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 7 years or above
  • 2\. If on allergy immunotherapy treatment this must be a stable regimen during the study
  • 3\. Be capable of producing valid FeNO measurements via the NObreath®
  • 4\. Be capable of performing spirometry in accordance with ATS/ERS criteria

Exclusion Criteria

  • 1\. Hospitalisation related to asthma in the past 6 months
  • 2\. Use of oral corticosteroid in the 4 weeks prior to visit 1
  • 3\. Use of biological therapies e.g. mepolizumab in 12 weeks prior to visit 1
  • 4\. Other respiratory diseases e.g. COPD or cystic fibrosis
  • 5\. Known intolerance to inhaled corticosteroids or salbutamol
  • 6\. Cardiovascular conditions:
  • 6\.1\. Coronary artery disease
  • 6\.2\. High blood pressure
  • 6\.3\. Heart failure
  • 6\.4\. Diagnosed abnormality of heart rhythm

Outcomes

Primary Outcomes

Not specified

Similar Trials